Funding the Future of Psychedelic Medicine in Europe: An Interview with Norrsken Mind Post published:July 3, 2024 Post category:Interviews
In Conversation: Joanna Kempner, Author of “Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine” Post published:June 18, 2024 Post category:Interviews
Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh Post published:April 12, 2024 Post category:Interviews/Pα+
Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program Post published:April 3, 2024 Post category:Interviews
Fluence’s Elizabeth Nielson on Professional Education for the Psychedelics Field Post published:March 19, 2024 Post category:Interviews/Pα+
Bay Staters for Natural Medicine Co-Founder, James Davis, on Grassroots Psychedelic Policy Reform, a Community-based Facilitator Network, and the Corporatisation of Psychedelics Post published:March 8, 2024 Post category:Interviews
A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and Promise of Medicinal Psychedelics” Post published:February 1, 2024 Post category:Interviews
Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape Post published:January 31, 2024 Post category:Interviews/Pα+
Pα+ Mini Interview with Ester Kincová and Steve Rolles: Regulating the Non-Medical Use of Psychedelics Post published:November 20, 2023 Post category:Interviews/Pα+
Pα+ Mini Interview with Eddie Jacobs: Post-Trial Provisions in Clinical Psychedelic Research Post published:November 20, 2023 Post category:Interviews/Pα+